Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 2, 1997, Pages 253-258

  Anscher, Mitchell S ^a,b   Kong, Feng Ming ^a   Marks, Lawrence B ^a   Bentel, Gunilla C ^a   Jirtle, Randy L ^a  

^a DUKE CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Complications; Radiation therapy; Transforming Growth Factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HODGKIN DISEASE; HUMAN; IONIZING RADIATION; LUNG CANCER; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYMOMA; TISSUE INJURY;

BIOLOGICAL MARKERS; HODGKIN DISEASE; HUMANS; LUNG NEOPLASMS; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; SENSITIVITY AND SPECIFICITY; THYMOMA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030978490     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00529-9     Document Type: Article

References (22)

1. Anscher, M. S.; Crocker, I. R.; Jirtle, R. L. Transforming growth factor-β1 expression in irradiated liver. Radiat Res. 122:77-85; 1990.
2. Anscher, M. S.; Kong, F.-M.; Murase, T.; Jirtle, R. L. Normal tissue injury after cancer therapy is a local response exacerbated by an endocrine effect of TGFβ. Brit. J. Radiol. 68:331-333; 1995.
3. Anscher, M. S.; Murase, T.; Prescott, D. M.; Marks, L. B.; Reisenbichler, H.; Bentel, G. C.; Spencer, D.; Sherouse, G.; Jirtle, R. L. Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 30:671-676; 1994.
4. Anscher, M. S.; Peters, W. P.; Reisenbichler, H.; Petros, W. P.; Jirtle, R. L. Transforming growth factor β as a predictor of lung and liver fibrosis after autologous bone marrow transplantation for advanced breast cancer. N. Engl. J. Med. 328:1592-1598; 1993.
5. Barcellos-Hoff, M. H. Redox mechanisms for activation of latent TGF-β. 43rd Annual Meeting of the Radiation Research Society abstract P14-196; 1995: 153.
6. Boersma, L. J.; Damen, E. M. F.; de Boer, R. W.; Muller, S. H.; Valdes Olmos, R. A.; Hoefnagel, C. A.; Roos, C. M.; van Zandwijk, N.; Lebesque, J. A new method to determine dose-effect relations for local lung-function changes using correlated SPECT and CT data. Radiother. Oncol. 29:110-116; 1993.
7. Border, W. A.; Ruoslahti, E. Transforming growth factor-β in disease: The dark side of tissue repair. J. Clin. Invest. 90:1-7; 1992.
8. Canney, P. A.; Dean, S. Transforming growth factor β: A promoter of late connective tissue injury following radiotherapy? Br. J. Radiol. 63:620-623; 1991.
9. Emami, B.; Lyman, J.; Brown, A.; Coia, L.; Goitein, M.; Munzenrider, J. E.; Shank, B.; Solin, L. J.; Wesson, M. Tolerance of normal tissues to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:109-122; 1991.
10. Kankaki, T.; Olofsson, A.; Moren, A.; Wernstedt, C.; Hellman, U.; Miyazono, K.; Claesson-Welsh, L.; Heldin, C.-H. TGF-β1 binding protein: A component of the large latent complex of TGF-β1 with multiple repeat sequences. Cell 61:1051-1061; 1990.
11. Kong, F.-M.; Anscher, M. S.; Murase, T.; Abbott, B. D.; Iglehart, J. D.; Jirtle, R. L. Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann. Surg. 222:155-162; 1995.
12. Krishnan, E. C.; Krishnan, L.; Jewell, B.; Bahatia, P.; Jewell, W. R. Dose-dependent radiation effect on microvasculature and repair. J. Natl. Cancer Inst. 79:1321-1325; 1987.
13. Letterio, J. J.; Geiser, A. G.; Kulkarni, A. B.; Roche, N. S.; Sporn, M. B.; Roberts, A. B. Maternal rescue of transforming growth factor-β1 null mice. Science 264:1936-1938; 1994.
14. Lyman, J. T.; Wolbarst, A. B. Optimization of radiation therapy III. A method of assessing complication probabilities from dose-volume histograms. Int. J. Radiat. Oncol. Biol. Phys. 113:103-109; 1987.
15. Lyons, R. M.; Gentry, L. E.; Purchio, A. F.; Moses, H. L. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J. Cell Biol. 110:1361-1367; 1990.
16. Marks, L. B.; Prosnitz, L. R. Estimation of normal tissue complication probabilities with three-dimensional technology. Int. J. Radiat. Oncol. Biol. Phys. 28:777-779; 1994.
17. Marks, L. B.; Spencer, D. P.; Bentel, G. C.; Sherouse, G. W.; Ray, S.; Sontag, M.; Coleman, R. E.; Jaszczak, R. J.; Turkington, T. G.; Tapson, V.; Prosnitz, L. R. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 26:659-668; 1993.
18. Murase, T.; Jirtle, R. L.; McDonald, G. B. Transforming growth factor-beta plasma concentrations in patients with leukemia and lymphoma receiving chemoradiotherapy and marrow transplantation [letter]. Blood 83:2383; 1994.
19. Oppenheim, J. J.; Neta, R. Pathophysiological roles of cytokines in development, immunity, and inflammation. FASEB J. 8:158-162; 1994.
20. Roberts, A. B.; Lamb, L. C.; Newton, D. L.; Sporn, M. B.; De Larco, J. E.; Todaro, G. J. Transforming growth factors: Isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc. Natl. Acad. Sci. USA 77:3494-3498; 1980.
21. Sporn, M. B.; Roberts, A. B. Transforming growth factor-β: Recent progress and new challenges. J. Cell Biol. 119:1017-1021; 1992.
22. Wahl, S. M. TGFβ in inflammation: A cause and a cure. J. Clin. Immunol. 12:61; 1992.